Henry C Deblasi, MD in Levittown, NY - Medicare Otolaryngology

Henry C Deblasi, MD is a medicare enrolled "Otolaryngology" physician in Levittown, New York. He went to New York Medical College and graduated in 1989 and has 35 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Joseph M Capo Md Pc and his current practice location is 2870 Hempstead Tpke, Suite 203, Levittown, New York. You can reach out to his office (for appointments etc.) via phone at (516) 731-6644.

Henry C Deblasi is licensed to practice in New York (license number 194260) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1639179377.

Contact Information

	Henry C Deblasi, MD
	2870 Hempstead Tpke, Suite 203, Levittown, NY 11756-1341
	(516) 731-6644
	(516) 731-8746

Physician's Profile

Full Name	Henry C Deblasi
Gender	Male
Speciality	Otolaryngology
Experience	35 Years
Location	2870 Hempstead Tpke, Levittown, New York
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Henry C Deblasi attended and graduated from New York Medical College in 1989

NPI Data:

NPI Number: 1639179377
Provider Enumeration Date: 07/22/2005
Last Update Date: 11/18/2009

Medicare PECOS Information:

PECOS PAC ID: 2365496726
Enrollment ID: I20050308001197

Medical Identifiers

Medical identifiers for Henry C Deblasi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639179377	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	194260 (New York)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Joseph M Capo Md Pc	7911899562	6

News Archive

OraSure registers $3.5 million net loss for full year 2010

OraSure Technologies, Inc., a market leader in oral fluid diagnostics, today announced revenues of $75.0 million and $18.8 million for the year and quarter ended December 31, 2010, respectively. This compares to revenues of $77.0 million and $20.9 million for the year and quarter ended December 31, 2009.

Anti-depressants are passing into waterways and affecting fish

Around one in four Montrealers take some kind of anti-depressant, and according to new research, the drugs are passing into the waterways and affecting fish. The findings are internationally significant as the city's sewage treatment system is similar to that in use in other major cities, and moreover, it is reputed to be the third largest treatment system in the world.

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

The foods that make up a heart healthy diet for people worldwide may differ from what was previously thought, according to late breaking results from the observational Prospective Urban Rural Epidemiological study presented today in a Hot Line Session at ESC Congress 2018 and simultaneously published in the Lancet.

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

Cook Medical announced that a new 5 mm diameter version of Zilver® PTX® was approved by the FDA. It is the first 5 mm drug-eluting stent in the U.S. with lengths available up to 140 mm that is indicated to treat vessels as small as 4mm in diameter.

NYU Langone webinar discusses advances in the treatment of RA

Steven Abramson, MD, professor of medicine and director of the rheumatology division at NYU Langone Medical Center, hosted a webinar with colleagues from the medical center for rheumatoid arthritis community bloggers - bringing together, bench, bedside and the blogosphere to discuss advances in the investigation, care, and treatment of RA.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Henry C Deblasi allows following entities to bill medicare on his behalf.

Entity Name	Joseph M Capo Md Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1063488658 PECOS PAC ID: 7911899562 Enrollment ID: O20100216000364

News Archive

OraSure registers $3.5 million net loss for full year 2010

Anti-depressants are passing into waterways and affecting fish

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

NYU Langone webinar discusses advances in the treatment of RA

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Henry C Deblasi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Henry C Deblasi, MD 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756-1341 Ph: (516) 731-6644	Henry C Deblasi, MD 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756-1341 Ph: (516) 731-6644

News Archive

OraSure registers $3.5 million net loss for full year 2010

Anti-depressants are passing into waterways and affecting fish

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

NYU Langone webinar discusses advances in the treatment of RA

Otolaryngology Doctors in Levittown, NY

Dr. Barak Greenfield, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3601 Hempstead Tpke Ste 110, Levittown, NY 11756 Phone: 516-579-3050 Fax: 516-579-6233
Joseph M Capo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2870 Hempstead Tpke, Ste 203, Levittown, NY 11756 Phone: 516-731-6644 Fax: 516-731-8746
Dr. Eliot Danziger, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 2870 Hempstead Tpke, Levittown, NY 11756 Phone: 516-579-3050 Fax: 516-579-6233
Joseph A Capo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756 Phone: 516-731-6644

Henry C Deblasi, MD - Medicare Otolaryngology in Levittown, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

OraSure registers $3.5 million net loss for full year 2010

Anti-depressants are passing into waterways and affecting fish

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

NYU Langone webinar discusses advances in the treatment of RA

Medicare Reassignments

OraSure registers $3.5 million net loss for full year 2010

Anti-depressants are passing into waterways and affecting fish

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

NYU Langone webinar discusses advances in the treatment of RA

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

OraSure registers $3.5 million net loss for full year 2010

Anti-depressants are passing into waterways and affecting fish

Foods that constitute heart healthy diet for people globally may vary from what was earlier thought

FDA approves new 5 mm diameter drug-eluting stent from Cook Medical

NYU Langone webinar discusses advances in the treatment of RA

Otolaryngology Doctors in Levittown, NY